Diethyl (3-bromopropyl)phosphonate → Diethyl [3-(7-ethyl-3-methylxanthin-1-yl)propyl]phosphonate

HRID 2027

Reaction equation

HRID 2027 reaction equation
[CH2:1]([N:3]1[C:11]2[C:10](=[O:12])[NH:9][C:8](=[O:13])[N:7]([CH3:14])[C:6]=2[N:5]=[CH:4]1)[CH3:2].Br[CH2:16][CH2:17][CH2:18][P:19]([O:24][CH2:25][CH3:26])(=[O:23])[O:20][CH2:21][CH3:22]>>[CH2:1]([N:3]1[C:11]2[C:10](=[O:12])[N:9]([CH2:16][CH2:17][CH2:18][P:19](=[O:23])([O:24][CH2:25][CH3:26])[O:20][CH2:21][CH3:22])[C:8](=[O:13])[N:7]([CH3:14])[C:6]=2[N:5]=[CH:4]1)[CH3:2]

Participants

3

Procedure

The title substance was prepared from 0.041 mol of 7-ethyl-3-methyl-xanthine and 0.049 mol of diethyl 3-bromopropanephosphonate analogously to Example 32.

Sources & evidence

ORD record
ord-b873039c08354be38bd2be8966ce1a89
Source dataset
uspto-grants-1998_03
Patent number
US05728686

Linked notes

Loading…